Mr. Mucus gets a new home

Share this article:

Mr. Mucus is going to work for Reckitt Benckiser, which bought Adams Respiratory Therapeutics, maker of the heavily advertised Mucinex franchise, for $2.3 billion. Though better known for its household cleaning products, Reckitt makes opiate dependency treatment Suboxone and recently bought two OTC meds from Boots. 

Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?